M.A. v. Regence BlueCross , 2020 UT App 177 ( 2020 )


Menu:
  •                         
    2020 UT App 177
    THE UTAH COURT OF APPEALS
    M.A.,
    Appellant,
    v.
    REGENCE BLUECROSS BLUESHIELD OF UTAH,
    Appellee.
    Opinion
    No. 20190885-CA
    Filed December 31, 2020
    Third District Court, Tooele Department
    The Honorable Matthew Bates
    No. 180301744
    Sara Pfrommer and Kathleen M. McConkie,
    Attorneys for Appellant
    Timothy C. Houpt and Jessica P. Wilde,
    Attorneys for Appellee
    JUDGE GREGORY K. ORME authored this Opinion, in which
    JUDGES MICHELE M. CHRISTIANSEN FORSTER and JILL M. POHLMAN
    concurred.
    ORME, Judge:
    ¶1     Regence BlueCross BlueShield of Utah (Regence) denied
    insurance coverage for a two-week biofeedback retraining
    program to treat M.A.’s chronic constipation. Following three
    internal appeals, in which Regence upheld its denial of coverage
    for the treatment, M.A. sued Regence alleging, in relevant part,
    breach of the implied covenant of good faith and fair dealing.
    The district court granted summary judgment in Regence’s
    favor. M.A. appeals, and we affirm.
    M.A. v. Regence BlueCross
    BACKGROUND1
    ¶2      M.A. is a beneficiary of a self-funded group health plan
    that her husband’s employer, Granite School District, sponsors.
    The school district engaged Regence to act as the administrator
    of the plan. An administrative services contract (the ASC)
    governs the relationship between Regence and the school
    district. The ASC delegates to Regence the authority to process
    claims and interpret the plan on the school district’s behalf,
    while the school district retains ‚the final responsibility and
    liability for payment of all benefits under the [plan+.‛
    Additionally, the ASC provides that the school district ‚may
    choose to delegate to Regence the discretionary authority to
    administer and make appeals decisions for all, some, or none of
    the member appeal levels.‛
    ¶3     Under the plan, with the exception of certain preventative
    care, ‚[t]o be covered, medical services and supplies must be
    Medically Necessary for the treatment of an Illness or Injury.‛
    Regence encourages beneficiaries of the plan to seek
    pre-authorization ‚to determine Medical Necessity prior to
    services being rendered.‛ To assist in its determination of
    whether a requested service is medically necessary, Regence
    typically requests the beneficiary’s medical records.
    ¶4     In June 2017, the Mayo Clinic sent Regence a
    pre-authorization request in which it diagnosed M.A. with
    ‚*c+hronic constipation secondary to pelvic floor dysfunction‛
    and requested that Regence authorize a ‚two-week pelvic
    retraining program‛ during which M.A. would ‚learn the
    1. ‚In reviewing a district court’s grant of summary judgment,
    we view the facts and all reasonable inferences drawn therefrom
    in the light most favorable to the nonmoving party and recite the
    facts accordingly.‛ Ockey v. Club Jam, 
    2014 UT App 126
    , ¶ 2 n.2,
    
    328 P.3d 880
     (quotation simplified).
    20190885-CA                    2                
    2020 UT App 177
    M.A. v. Regence BlueCross
    techniques and undergo biofeedback therapy[2] to optimize
    pelvic floor muscle function during defecation.‛
    ¶5     Regence applies criteria listed under the Biofeedback
    Allied Health Policy Number 32 (the Biofeedback Criteria) in
    determining whether biofeedback treatment is medically
    necessary. Per the Biofeedback Criteria, ‚up to six biofeedback
    sessions over three months‛ may be medically necessary for
    adults suffering from ‚Dyssynergia-type constipation‛3 when
    three criteria are met:
    1.     Symptoms of functional constipation that
    meet all (a–c) of the following ROME III
    criteria:
    a.      Two or more of the following
    symptoms (i–vi) have been present
    for the past three months, with
    symptom onset at least six months
    prior to diagnosis:
    2. ‚Biofeedback is a technique *patients+ can use to learn to
    control some of *their+ body’s functions, such as . . . heart rate.
    During biofeedback, [patients are] connected to electrical sensors
    that help [them] receive information about *their+ body.‛
    Biofeedback, Mayo Clinic, https://www.mayoclinic.org/tests-
    procedures/biofeedback/about/pac-20384664 [https://perma.cc/
    C5LW-KEG8+. It is ‚used to help manage‛ constipation and
    many other ‚physical and mental health issues.‛ Id.
    3. Pelvic floor muscles ‚must relax in a coordinated manner
    . . . to successfully eliminate stool from [the] rectum,‛ and pelvic
    floor dyssynergia is marked by the failure of the muscles to
    relax, resulting in constipation. Pelvic Floor Dyssynergia, Stanford
    Health Care, https://stanfordhealthcare.org/medical-conditions/
    digestion-and-metabolic-health/pelvic-floor-dyssynergia.html [h
    ttps://perma.cc/J4T2-3UYW].
    20190885-CA                     3                
    2020 UT App 177
    M.A. v. Regence BlueCross
    i.      Straining during at least 25%
    of defecations
    ii.     Lumpy or hard stools in at
    least 25% of defecations
    iii.    Sensation      of      incomplete
    evacuation for at least 25% of
    defecations
    iv.     Sensation       of       anorectal
    obstruction/blockage for at
    least 25% of defecations
    v.      Manual maneuvers to facilitate
    at least 25% of defecations
    (e.g.,   digital      evacuation,
    support of the pelvic floor)
    vi.     Fewer than three defecations
    per week
    b.     Loose stools are rarely present
    without the use of laxatives
    c.     Insufficient criteria for irritable bowel
    syndrome
    2.      Objective physiologic evidence of pelvic
    floor dyssynergia when one or both of the
    following criteria are met:
    a.     Inappropriate contraction of the
    pelvic floor muscles
    b.     Less than 20% relaxation of basal
    restricting sphincter pressure by
    manometry, imaging, or EMG
    3.      Failed 3-month trial of standard treatments
    for constipation including laxatives, dietary
    changes, and pelvic floor exercises
    ¶6    In response to the Mayo Clinic’s pre-authorization
    request, Regence wrote the Mayo Clinic and asked for medical
    documentation on whether M.A. suffered from ‚dyssynergia
    type constipation‛ and whether she met the Biofeedback
    20190885-CA                      4                
    2020 UT App 177
    M.A. v. Regence BlueCross
    Criteria, which Regence listed in its letter. The Mayo Clinic
    forwarded M.A.’s medical records to Regence the following day.
    ¶7      Regence denied the requested pre-authorization. In a
    letter dated July 21, 2017, Regence informed M.A. that, based on
    the determination of a physician who reviewed the request
    (Physician Reviewer 1), the requested services were not
    medically necessary because
    [t]he clinical documentation we received from your
    doctor does not clearly show:
        That you have         dyssynergia    type   of
    constipation.
        Documentation does not clearly show
    functional constipation, or how long it has
    been present.
        Objective evidence was not received, and
    unclear if you have failed a 3 month trial of
    standard treatment for constipation.
    This letter, and every subsequent letter of denial, listed the
    Biofeedback Criteria in their entirety. The letter also informed
    M.A. of Regence’s appeals process, including two levels of
    internal appeals followed by an external review by an
    independent review organization (IRO). The letter stated that
    M.A. could include additional information not previously
    considered with each new appeal.
    ¶8     The Mayo Clinic appealed the denial on M.A.’s behalf.
    The appeal included a letter from one of the Mayo Clinic’s
    gastroenterology and hepatology specialists (Specialist).
    Specialist stated that ‚*i+t was our impression that *M.A.+ has
    constipation due to pelvic floor dysfunction‛ and that ‚*t+his
    diagnosis was supported by the patient’s symptoms, our clinical
    20190885-CA                     5                 
    2020 UT App 177
    M.A. v. Regence BlueCross
    findings, and diagnostic tests.‛ Specialist believed that M.A.
    ‚would benefit considerably from pelvic floor retraining,‛ which
    ‚is universally accepted as the cornerstone for treating patients
    with obstructed defecation.‛ Specialist also included an
    academic article that supported biofeedback as a treatment for
    constipation but did not forward any additional medical records
    concerning M.A.’s condition or its prior treatment.
    ¶9     In resolving the appeal, a second physician (Physician
    Reviewer 2) reviewed M.A.’s medical records to determine
    whether the requested treatment was medically necessary.
    Physician Reviewer 2 upheld the denial. Specifically, she
    determined that (1) the records did not establish that any of the
    listed symptoms had been present for the past three months;
    (2) the sub-criterion of ‚*i+nappropriate contraction of pelvic
    floor muscles‛ was met, thus satisfying criterion 2;4 and (3) the
    records did not document a ‚*f+ailed 3-month trial of standard
    treatments for constipation.‛ In sum, Physician Reviewer 2
    concluded that M.A.’s medical records did not establish that her
    symptoms satisfied the first and third requirements of the
    Biofeedback Criteria.
    ¶10 On July 27, 2017, Regence notified M.A. of Physician
    Reviewer 2’s decision, stating,
    The clinical documentation we received from your
    doctor does not clearly show how long your
    symptoms have been present and does not
    establish that your symptoms meet the ROME III
    criteria listed below. In addition, while the
    documentation indicates that you have been taking
    Senna and Linzess, it is unclear that you have
    4. Physician Reviewer 2 also determined that M.A. had not met
    sub-criterion 2.b., but criterion 2 requires only that ‚one or both‛
    of sub-criteria 2.a. and 2.b. is met.
    20190885-CA                     6                
    2020 UT App 177
    M.A. v. Regence BlueCross
    failed a 3-month trial of standard treatments for
    constipation including laxatives, dietary change,
    and pelvic floor exercises. Your health plan does
    not cover services that are not medically necessary.
    ¶11 In August 2017, M.A. filed her own appeal in which she
    provided additional medical records from University of Utah
    Healthcare, Utah Gastroenterology, and Wasatch Endoscopy
    Center. This time, Regence forwent a second internal review and
    instead forwarded the appeal to an IRO. A board-certified
    physician in gastroenterology and internal medicine (Physician
    Reviewer 3) performed the review.5 Physician Reviewer 3
    concluded that ‚*b+ased on the submitted documentation,
    biofeedback training with pelvic floor training . . . would not be
    medically necessary according to‛ the Biofeedback Criteria.
    Specifically, he determined:
    Although the patient does have incomplete
    evacuation and frequent altered bowel habits, the
    nature and frequency is not estimated in the
    documentation.     Based    on    the     submitted
    documentation      and    medical      policy    for
    dyssynergia-type constipation all criterion are not
    met. . . . Biofeedback training is not medically
    necessary as criterion . . . 1.a. is not met. The
    documentation does not state that the patient has
    had straining, lumpy or hard stools, or sensation of
    incomplete defecation with at least 25% of
    defecations; sensation of anorectal obstruction; or
    manual maneuvers to facilitate defecation for at
    5. In addition to the review, Physician Reviewer 3 attested,
    among other things, that he did ‚not accept compensation that is
    dependent in any way on the outcome of the case‛ and that he
    ‚was not involved with the specific episode of care prior to this
    review.‛
    20190885-CA                     7               
    2020 UT App 177
    M.A. v. Regence BlueCross
    least 25% of the time or fewer than 3 defecations
    per week. The policy criterion . . . 1.b. and c. also
    require that the patient have loose stools rarely
    without use of laxatives and does not meet criteria
    for irritable bowel syndrome. Policy criteria [2.a.
    and 2.b.] are also not met as there is no
    documentation of inappropriate contractions of the
    pelvic floor muscles, or less than measured 20%
    relaxation of basal resting sphincter pressure. The
    only criterion met is documentation of failure of
    three months of standard treatments for
    constipation.
    Based on this independent review, Regence notified M.A. in a
    letter dated August 30, 2017, that the IRO upheld its decision to
    deny pre-authorization.
    ¶12 In February 2018, M.A., through counsel, appealed with
    Regence a final time. As part of the appeal, M.A. submitted
    letters from several of her treating physicians, including a
    second letter from Specialist, dated December 22, 2017. In this
    letter, Specialist stated that in his opinion, M.A. ‚has
    dyssynergia type constipation,‛ ‚had been afflicted with
    functional constipation for at least 36 months,‛ and ‚has failed a
    3-month trial of local, standard treatment for constipation.‛ He
    concluded, ‚I have reviewed the denial criteria sent to *M.A.+ by
    Regence, and it is my professional opinion that she has met each
    of the criteria specified there.‛ Regence forwarded this third
    appeal to a second IRO for review. A physician certified by the
    American Board of Internal Medicine in General Internal
    Medicine and Gastroenterology (Physician Reviewer 4) upheld
    Regence’s decision. Although Physician Reviewer 4 concluded
    that M.A. satisfied the second and third criteria, she determined
    that M.A.’s records did ‚not definitively document*+‛ any of the
    requisite symptoms listed under the first criterion. Physician
    Reviewer 4 also concluded that ‚the provided records do not
    clearly document that functional constipation has been ruled
    20190885-CA                     8               
    2020 UT App 177
    M.A. v. Regence BlueCross
    out, and therefore the [Biofeedback Criteria] are not met, and the
    guidelines and literature do not necessarily support the request
    for biofeedback therapy as medically necessary.‛
    ¶13 In November 2018, M.A. sued Regence in district court,
    alleging breach of contract, breach of the covenant of good faith
    and fair dealing, and intentional infliction of emotional distress.
    Regence moved for summary judgment, which the court granted
    following a hearing. The court ruled that the breach of the
    covenant of good faith and fair dealing and intentional infliction
    of emotional distress claims ‚fail as a matter of law‛ because
    ‚Regence’s denial of benefits was ‘fairly debatable.’‛ The court
    stated that ‚[s]pecifically, Regence relied on the opinions of four
    physicians to reach its conclusion that the requested treatment
    was not medically necess[ary] under the . . . Biofeedback
    Criteria,‛ whereas the letters and medical records M.A.
    submitted ‚contained conclusory statements and did not
    support the requisite elements and factors in the criteria.‛ The
    court also concluded that the breach of contract claim ‚fails
    because [M.A.] and Regence have no contract with each other.‛
    ¶14 M.A. appealed the district court’s decision to the Utah
    Supreme Court, which transferred the matter to us for
    resolution.
    ISSUE AND STANDARD OF REVIEW
    ¶15 M.A. raises one issue that we address on the merits. 6 She
    argues that the district court erred in granting summary
    6. M.A. also argues that the district court erred in granting
    summary judgment on her breach of contract claim on the
    ground that ‚*she+ and Regence have no contract with each
    other.‛ She argues that although she ‚is not a direct party to the
    [ASC+,‛ she nonetheless had the right to sue for breach of
    contract because ‚she is clearly and expressly an intended
    (continued…)
    20190885-CA                     9               
    2020 UT App 177
    M.A. v. Regence BlueCross
    (…continued)
    beneficiary of the contract with respect to the claims review and
    appeals process conducted by Regence.‛ See Reperex, Inc. v.
    Coldwell Banker Com., 
    2018 UT 51
    , ¶ 49, 
    428 P.3d 1082
    (‚*T+hird-party beneficiary status [is] an exception to the
    requirement of privity.‛) (quotation simplified); Bybee v. Abdulla,
    
    2008 UT 35
    , ¶ 36, 
    189 P.3d 40
     (‚A third party may claim a
    contract benefit only if the parties to the contract clearly express
    an intention to confer a separate and distinct benefit on the third
    party.‛) (quotation simplified).
    But M.A. did not raise this argument below and, thus, it is
    not preserved for appeal. Indeed, during the hearing on
    Regence’s motion for summary judgment, the court itself raised
    the question of whether M.A. was a third-party beneficiary of
    the ASC but expressly declined to ‚consider that theory‛
    because it ‚was not raised in the briefing.‛ M.A. contends that in
    opposing summary judgment, she argued ‚that Regence’s
    oversight and responsibility for the claims administration
    process created an obligation directly to *her+‛ and that although
    she cited unrelated legal authority, she presented a foundation
    for the third-party-beneficiary argument that was sufficient to
    allow the court to rule on the issue. See Torian v. Craig, 
    2012 UT 63
    , ¶ 20, 
    289 P.3d 479
    . But an inspection of her memorandum
    reveals that M.A. argued only that Regence does not lose ‚any
    culpability for bad faith decisions simply because [the school
    district+ pays its employees’ medical bills directly.‛ This
    assertion did not sufficiently raise her third-party-beneficiary
    argument. Accordingly, this issue is not preserved for appeal,
    and because M.A. does not ask us to review this issue pursuant
    to any of the exceptions to our preservation requirement, we do
    not address it further. See State v. Sanchez, 
    2018 UT 31
    , ¶ 30, 
    422 P.3d 866
     (stating that for an issue to be preserved for appeal, it
    ‚must be sufficiently raised to a level of consciousness before the
    trial court and must be supported by evidence or relevant legal
    authority‛) (quotation simplified).
    20190885-CA                     10               
    2020 UT App 177
    M.A. v. Regence BlueCross
    judgment in Regence’s favor on her breach of the implied duty
    of good faith and fair dealing claim on the ground that Regence’s
    denial of coverage was ‚fairly debatable.‛7 ‚We review a district
    court’s grant of summary judgment for correctness and afford no
    deference to the court’s legal conclusions.‛ Jones v. Farmers Ins.
    Exch., 
    2012 UT 52
    , ¶ 6, 
    286 P.3d 301
     (quotation simplified).8
    ANALYSIS
    ¶16 An insurer owes an implied duty of good faith and fair
    dealing to an insured.9 Jones v. Farmers Ins. Exch., 
    2012 UT 52
    , ¶ 7,
    7. M.A. does not appeal the district court’s grant of summary
    judgment in Regence’s favor on her intentional infliction of
    emotional distress claim.
    8. The Jones court also noted that ‚because of the complexity and
    variety of the facts upon which the fairly debatable
    determination depends,‛ we afford the district court’s decision
    ‚some deference‛ when that determination is fact intensive.
    Jones v. Farmers Ins. Exch., 
    2012 UT 52
    , ¶¶ 6, 13, 
    286 P.3d 301
    (quotation simplified). And it made this statement in the context
    of reviewing a summary judgment. It is difficult to square this
    deference with the as-a-matter-of-law determination that typifies
    appellate review of summary judgments. But we need not
    wrestle with the question here. Even according the district
    court’s decision no deference, we readily conclude that it
    correctly ruled, as a matter of law, that M.A.’s entitlement to the
    requested treatment was fairly debatable.
    9. Despite concluding that there was no contractual privity
    between M.A. and Regence, the district court addressed M.A.’s
    implied duty of good faith and fair dealing argument, which is
    based in contract law. Because we affirm the court’s grant of
    summary judgment on the ground that M.A.’s claim was fairly
    (continued…)
    20190885-CA                     11               
    2020 UT App 177
    M.A. v. Regence BlueCross
    
    286 P.3d 301
    . The duty ‚contemplates, at the very least, that the
    insurer will diligently investigate the facts to enable it to
    determine whether a claim is valid, will fairly evaluate the claim,
    and will thereafter act promptly and reasonably in rejecting or
    settling the claim.‛ Beck v. Farmers Ins. Exch., 
    701 P.2d 795
    , 801
    (Utah 1985). In the context of first-party insurance claims,10 an
    (…continued)
    debatable, we need not decide whether Regence, the third-party
    administrator of a self-funded group health plan, who is not the
    insurer in contractual privity with M.A., owes the contractually
    implied duty of good faith and fair dealing to plan beneficiaries.
    See Fire Ins. Exch. v. Oltmanns, 
    2018 UT 10
    , ¶ 61, 
    416 P.3d 1148
    (Durham, J., concurring in part and concurring in the result)
    (‚Although in the third-party context an insurer’s breach of its
    duties as a fiduciary can expose the insurer to punitive damages
    in tort liability, a breach of the implied duty of good faith and
    fair dealing in the first-party context only permits remedies in
    contract law.‛); Beck v. Farmers Ins. Exch., 
    701 P.2d 795
    , 800 (Utah
    1985) (‚*I+n a first-party relationship between an insurer and its
    insured, the duties and obligations of the parties are contractual
    rather than fiduciary. Without more, a breach of those implied or
    express duties,‛ including the implied duty to act in good faith,
    ‚can give rise only to a cause of action in contract, not one in
    tort.‛). See also Wolf v. Prudential Ins. Co. of Am., 
    50 F.3d 793
    , 797
    (10th Cir. 1995) (holding, based on Oklahoma law, that the
    determination of whether a third-party administrator owes a
    duty of good faith to an insured ‚should focus . . . on the factual
    question of whether the administrator acts like an insurer such
    that there is a ‘special relationship’ between the administrator
    and insured that could give rise to a duty of good faith‛). Thus,
    for purposes of this issue, we treat Regence as we would a ‚true‛
    insurer in contractual privity with the insured.
    10. ‚First-party‛ refers ‚to an insurance agreement where the
    insurer agrees to pay claims submitted to it by the insured for
    (continued…)
    20190885-CA                      12               
    2020 UT App 177
    M.A. v. Regence BlueCross
    insurer acts reasonably in denying a claim ‚if the insured’s claim
    is fairly debatable.‛ Prince v. Bear River Mutual Ins. Co., 
    2002 UT 68
    , ¶ 28, 
    56 P.3d 524
    . This is because if ‚an insured’s claim . . . is
    fairly debatable, then the insurer is entitled to debate it and
    cannot be held to have breached the implied covenant if it
    chooses to do so.‛ 
    Id.
     (quotation simplified). Thus, even though
    an insured’s claim might ultimately be found to be proper, an
    insurer has not breached the duty of good faith if, at the time of
    denial, the insured’s claim was fairly debatable. Jones, 
    2012 UT 52
    , ¶ 7.
    ¶17 Of course, an insurer will not prevail on summary
    judgment simply by asserting that a claim is fairly debatable. Id.
    ¶¶ 9, 12. ‚An analysis of whether an insurance claim is fairly
    debatable is closely related to an analysis of whether an insurer
    fulfilled its duty . . . to evaluate the claim fairly.‛ Id. ¶ 12.
    Accordingly, ‚*w+hen making the determination of whether a
    claim is fairly debatable, a judge should remain mindful of an
    insurer’s implied duties to diligently investigate claims, evaluate
    claims fairly, and act reasonably and promptly in settling or
    denying claims.‛ Id. A claim is therefore fairly debatable as a
    matter of law ‚only when there is a legitimate factual issue as to
    the validity of the insured’s claim, such that reasonable minds
    could not differ as to whether the insurer’s conduct measured up
    to the required standard of care.‛ Id. (quotation simplified).
    (…continued)
    losses suffered by the insured.‛ Beck, 701 P.2d at 798 n.2. ‚In
    contrast, a ‘third-party’ situation is one where the insurer
    contracts to defend the insured against claims made by third
    parties against the insured and to pay any resulting liability, up
    to the specified dollar limit.‛ Id. See also Oltmanns, 
    2018 UT 10
    ,
    ¶¶ 38–39 (Durham, J., concurring in part and concurring in the
    result) (distinguishing the relationship between the insurer and
    the insured in the context of first-party and third-party claims).
    20190885-CA                      13               
    2020 UT App 177
    M.A. v. Regence BlueCross
    ¶18 Here, M.A. argues that when viewing the facts in a light
    most favorable to her as the nonmoving party, her request for
    pre-authorization was not fairly debatable because her medical
    records contradicted Regence’s basis for denying treatment—i.e.,
    that she had not established medical necessity by satisfying the
    Biofeedback Criteria. She contends that ‚*g+iven the unequivocal
    professional opinion of [Specialist] that directly contravened
    Regence’s stated basis for the denial, a jury could conclude that
    Regence did not act reasonably when it denied coverage.‛ She
    further asserts that ‚*t+he fact that Regence utilized the services
    of a medical professional—or even more than one medical
    professional—in denying [her] coverage does not establish as a
    matter of law that Regence’s denial was reasonable, but only that
    Regence has access to doctors who will support its initial
    conclusions.‛11
    ¶19 In making these arguments, M.A. relies heavily on
    Specialist’s second letter in which he stated that in his
    professional opinion, M.A. ‚has dyssynergia type constipation,‛
    ‚had been afflicted with functional constipation for at least 36
    11. M.A. also argues that summary judgment was inappropriate
    because ‚there are material facts in dispute as to what
    information Regence used to deny *her+ request for coverage.‛
    But apart from her heavy reliance on Specialist’s second letter
    and a passing and generalized reference to her medical records,
    unsupported by citations to the record or any focused discussion
    of which specific dates and ‚description of the illness‛ contained
    therein would satisfy any of the Biofeedback Criteria, M.A. does
    not identify which records, if considered by Regence in denying
    her claim, would render its denial of coverage a breach of the
    implied covenant of good faith and fair dealing. See Utah R.
    App. P. 24(a)(8). And as hereinafter discussed, Specialist’s
    second letter—which Specialist wrote after the second appeal
    failed—was insufficient, at the very least, to satisfy the first
    criterion.
    20190885-CA                    14               
    2020 UT App 177
    M.A. v. Regence BlueCross
    months,‛ and ‚has failed a 3-month trial of local, standard
    treatment for constipation.‛ The letter concluded with
    Specialist’s statement that following his review of ‚the denial
    criteria sent to [M.A.] by Regence, . . . it is [his] professional
    opinion that she has met each of the criteria specified there.‛
    M.A. contends that ‚*w+hen a well-respected expert treating
    physician addresses the reasons for denial of coverage point by
    point, and informs the insurer that in his professional opinion,
    treatment is medically necessary as defined by the insurer’s own
    standards, there is an obvious material dispute of fact that makes
    summary judgment inappropriate.‛
    ¶20 The Biofeedback Criteria permitted Regence to approve
    ‚up to six biofeedback sessions over three months‛ for adults
    suffering from ‚*d]yssynergia-type constipation‛ when three
    criteria are met. Physician Reviewer 1 initially denied coverage
    because (A) the medical records did ‚not clearly show‛ that
    M.A. suffered from ‚dyssynergia type of constipation‛; (B) the
    records did ‚not clearly show functional constipation, or how
    long it has been present‛ (referring to criterion 1);
    (C) ‚*o+bjective evidence was not received‛ (referring to criterion
    2); and (D) it was ‚unclear if *M.A.+ failed a 3 month trial of
    standard treatment for constipation‛ (referring to criterion 3). At
    the time of denial, Physician Reviewer 1 did not have access to
    Specialist’s second letter when reviewing the Mayo Clinic’s
    pre-authorization request. It was not until the third and final
    appeal that M.A. provided the letter, dated December 22, 2017,
    for Physician Reviewer 4 to consider. Thus, the initial denial and
    subsequent two appeals upholding the denial cannot be deemed
    unreasonable on the basis that the letter refuted the denials. See
    Jones, 
    2012 UT 52
    , ¶ 7 (‚An insurer cannot be held to have
    breached the covenant of good faith on the ground that it
    wrongfully denied coverage if the insured’s claim, although later
    found to be proper, was fairly debatable at the time it was
    denied.‛) (quotation simplified). And M.A. has not directed us to
    the contents of the remaining medical records she made
    available to Regence that contradict the physician reviewers’
    20190885-CA                    15               
    2020 UT App 177
    M.A. v. Regence BlueCross
    determinations that M.A. had not satisfied the Biofeedback
    Criteria.
    ¶21 In any event, even for purposes of the final IRO appeal,
    Specialist’s second letter did not satisfy the first criterion—the
    criterion that all four physician reviewers agreed was not even
    partially met. The first criterion requires that medical records
    show:
    1.      Symptoms of functional constipation that
    meet all (a–c) of the following ROME III
    criteria:
    a.      Two or more of the following
    symptoms (i–vi) have been present
    for the past three months, with
    symptom onset at least six months
    prior to diagnosis:
    i.     Straining during at least 25%
    of defecations
    ii.    Lumpy or hard stools in at
    least 25% of defecations
    iii.   Sensation     of     incomplete
    evacuation for at least 25% of
    defecations
    iv.    Sensation      of      anorectal
    obstruction/blockage for at
    least 25% of defecations
    v.     Manual maneuvers to facilitate
    at least 25% of defecations
    (e.g.,   digital    evacuation,
    support of the pelvic floor)
    vi.    Fewer than three defecations
    per week
    b.      Loose stools are rarely present
    without the use of laxatives
    20190885-CA                     16               
    2020 UT App 177
    M.A. v. Regence BlueCross
    c.     Insufficient criteria for irritable bowel
    syndrome
    ¶22 Specialist’s second letter did not address any of the
    requisite symptoms listed under the first criterion. Instead, it
    included the blanket statement that in Specialist’s opinion, M.A.
    ‚has dyssynergia type constipation.‛ But the Biofeedback
    Criteria approved biofeedback treatment for adults suffering
    from dyssynergia type constipation if they satisfied the three
    criteria. Accordingly, the fact that M.A. suffered from
    dyssynergia type constipation alone does not satisfy the first
    criterion. Furthermore, without discussion by Specialist of
    M.A.’s specific symptoms, it was reasonable for Regence and
    Physician Reviewer 4 not to rely on Specialist’s blanket
    statement that based on his review of ‚the denial criteria sent to
    [M.A.] by Regence,‛ which included the Biofeedback Criteria in
    their entirety, ‚it is [his] professional opinion that she has met
    each of the criteria specified there.‛
    ¶23 We therefore agree with the district court that the medical
    records and letters M.A. has brought to our attention ‚did not
    support the requisite elements and factors in the [Biofeedback
    Criteria].‛ Because M.A. has not shown how the medical records
    she submitted to Regence contradicted Regence’s claim that her
    symptoms did not meet, at the very least, the first criterion of the
    Biofeedback Criteria, a ‚legitimate factual issue as to the validity
    of *M.A.’s+ claim‛ existed. See Jones, 
    2012 UT 52
    , ¶ 12 (quotation
    simplified). Accordingly, M.A.’s entitlement to coverage for the
    treatment that was the subject of her pre-authorization request
    was fairly debatable, and Regence’s denial was therefore
    reasonable.
    CONCLUSION
    ¶24 Because M.A. has not directed the district court’s
    attention or ours to medical records indicating that she
    experienced any of the symptoms listed in the first criterion of
    20190885-CA                     17               
    2020 UT App 177
    M.A. v. Regence BlueCross
    the Biofeedback Criteria, it was fairly debatable whether the
    requested biofeedback treatment was medically necessary.
    Regence therefore did not breach the implied duty of good faith
    and fair dealing, as a matter of law, when it denied coverage.
    ¶25   Affirmed.
    20190885-CA                   18               
    2020 UT App 177